Pharmacokinetics of Tranexamic Acid (TXA) in Children Undergoing Repair of Congenital Heart Defects Utilizing Cardiopulmonary Bypass

Completed

Conditions studied: Congenital Heart Disease

In brief

The purpose of this study is to measure blood levels of TXA in children having cardiac surgery which requires cardiopulmonary bypass. TXA is used to reduce bleeding during surgery. This study will help determine if the current dosing of TXA results in therapeutic blood levels.

Key facts

Study ID

NCT01045356

Run by

Boston Children's Hospital

People needed

55

Starts

2010-01-01

Expected to finish

2014-12-01

Last updated by the study team

2015-07-30

Who can join

Age: any, up to 21. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• congenital heart disease requiring surgical repair with cardiopulmonary bypass

You may not qualify if…

• children weighing over 20 kg
• family does not want to participate in the study

Where it is running

• Children's Hospital Boston — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.